Literature DB >> 23820867

Commentary on "Uttley L, Campbell F, Rhodes M et al. Minimally invasive esophagectomy versus open surgery: is there an advantage? Surg Endosc 2013;27(3):724-731".

Emma Hamilton1, Ewen A Griffiths.   

Abstract

Mesh：

Year:  2013        PMID： 23820867     DOI： 10.1007/s00464-013-3067-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN： 0930-2794            Impact factor:   4.584


× No keyword cloud information.
  5 in total

Review 1.  Minimally invasive oesophagectomy versus open surgery: is there an advantage?

Authors:  Lesley Uttley; Fiona Campbell; Michael Rhodes; Anna Cantrell; Heather Stegenga; Myfanwy Lloyd-Jones
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

2.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

3.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.

Authors:  Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

4.  Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.

Authors:  James Fleshman; Daniel J Sargent; Erin Green; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; Heidi Nelson
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

5.  Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.

Authors:  Nicolas Briez; Guillaume Piessen; Franck Bonnetain; Cécile Brigand; Nicolas Carrere; Denis Collet; Christophe Doddoli; Renaud Flamein; Jean-Yves Mabrut; Bernard Meunier; Simon Msika; Thierry Perniceni; Frédérique Peschaud; Michel Prudhomme; Jean-Pierre Triboulet; Christophe Mariette
Journal:  BMC Cancer       Date:  2011-07-23       Impact factor: 4.430
  5 in total
  1 in total

1.  Minimally invasive esophagectomy versus open surgery: is there an advantage?

Authors:  Lesley Uttley; Fiona Campbell; Michael Rhodes; Anna Cantrell; Heather Stegenga; Myfanwy Lloyd-Jones
Journal:  Surg Endosc       Date:  2013-06-27       Impact factor: 4.584
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.